Xiang Li

Xiang Li

Auto-generated profile, based on publicly available information

Xiang Li

Department of Intelligent Systems Engineering, Indiana University, Bloomington, USA

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 July 2018 in Lab on a Chip
Verified
Journal Article
Closed access
PDF file
XLXiang Li
Xiang Li
SGSubin M. George
Subin M. George
LVLawrence Vernetti
Lawrence Vernetti
AGAlbert Gough
Albert Gough
DTD. Lansing Taylor
D. Lansing Taylor
We developed a glass based, vascularized human biomimetic liver MPS recreating oxygen zonation present in the liver acinus.

10 January 2018 in Frontiers in Physiology
Verified
Journal Article
Open access
FGFeng Gao
Feng Gao
BLBrandon P. Lucke-Wold
Brandon P. Lucke-Wold
XLXiang Li
Xiang Li
ALAric F. Logsdon
Aric F. Logsdon
LXLi-Chong Xu
Li-Chong Xu
PHPingnian He
Pingnian He
Nitric oxide (NO) is a known anti-adhesive molecule that prevents platelet aggregation and leukocyte adhesion to endothelial cells (ECs). The mechanism has been attributed to its role in the regulation of adhesion molecules on leukocytes and the adhesive properties of platelets. Our previous study conducted in rat venules found that reduction of EC basal NO synthesis caused EC ICAM-1-mediated firm adhesion of leukocytes within 10–30 min. This quick response occurred in the absence of alterations of adhesion molecules on leukocytes and also opposes the classical pattern of ICAM-1-mediated leukocyte adhesion that requires protein synthesis and occurs hours after stimulation. The objective of this study is to investigate the underlying mechanisms of reduced basal NO-induced EC-mediated rapid leukocyte adhesion observed in intact microvessels. The relative levels of ICAM-1 at different cell regions and their activation status were determined with cellular fractionation and western blot using cultured human umbilical vein ECs. ICAM-1 adhesiveness was determined by immunoprecipitation in non-denatured proteins to assess the changes in ICAM-1 binding to its inhibitory antibody, mAb1A29, and antibody against total ICAM-1 with and without NO reduction. The adhesion strength of EC ICAM-1 was assessed by atomic force microscopy (AFM) on live cells. Results showed that reduction of EC basal NO caused by the application of caveolin-1 scaffolding domain (AP-CAV) or NOS inhibitor, L-NMMA, for 30 min significantly increased phosphorylated ICAM-1 and its binding to mAb1A29 in the absence of altered ICAM-1 expression and its distribution at subcellular regions. The Src inhibitor, PP1, inhibited NO reduction-induced increases in ICAM-1 phosphorylation and adhesive binding. AFM detected significant increases in the binding force between AP-CAV-treated ECs and mAb1A29-coated probes. These results demonstrated that reduced EC basal NO lead to a rapid increase in ICAM-1 adhesive binding via Src-mediated phosphorylation without de novo protein synthesis and translocation. This study suggests that a NO-dependent conformational change of constitutive EC membrane ICAM-1 might be the mechanism of rapid ICAM-1 dependent leukocyte adhesion observed in vivo. This new mechanistic insight provides a better understanding of EC/leukocyte interaction-mediated vascular inflammation under many disease conditions that encounter reduced basal NO in the circulation system.

24 June 2012 in Biomedical Microdevices
Verified
Journal Article
Closed access
PDF file
ZHZhouchun Huang
Zhouchun Huang
XLXiang Li
Xiang Li
MMManuela Martins-Green
Manuela Martins-Green
YLYuxin Liu
Yuxin Liu

1 April 2013 in Sensors and Actuators A: Physical
Verified
Journal Article
Closed access
XLXiang Li
Xiang Li
NWNianqiang Wu
Nianqiang Wu
YRYon Rojanasakul
Yon Rojanasakul
YLYuxin Liu
Yuxin Liu

12 May 2015 in PLOS ONE
Verified
Journal Article
Open access
PDF file
XLXiang Li
Xiang Li
SXSulei Xu
Sulei Xu
PHPingnian He
Pingnian He
YLYuxin Liu
Yuxin Liu
Microfluidic technologies enable in vitro studies to closely simulate in vivo microvessel environment with complexity. Such method overcomes certain constrains of the statically cultured endothelial monolayers and enables the cells grow under physiological range of shear flow with geometry similar to microvessels in vivo. However, there are still existing knowledge gaps and lack of convincing evidence to demonstrate and quantify key biological features of the microfluidic microvessels. In this paper, using advanced micromanufacturing and microfluidic technologies, we presented an engineered microvessel model that mimicked the dimensions and network structures of in vivo microvessels with a long-term and continuous perfusion capability, as well as high-resolution and real-time imaging capability. Through direct comparisons with studies conducted in intact microvessels, our results demonstrated that the cultured microvessels formed under perfused conditions recapitulated certain key features of the microvessels in vivo. In particular, primary human umbilical vein endothelial cells were successfully cultured the entire inner surfaces of the microchannel network with well-developed junctions indicated by VE-cadherin staining. The morphological and proliferative responses of endothelial cells to shear stresses were quantified under different flow conditions which was simulated with three-dimensional shear dependent numerical flow model. Furthermore, we successfully measured agonist-induced changes in intracellular Ca2+ concentration and nitric oxide production at individual endothelial cell levels using fluorescence imaging. The results were comparable to those derived from individually perfused intact venules. With in vivo validation of its functionalities, our microfluidic model demonstrates a great potential for biological applications and bridges the gaps between in vitro and in vivo microvascular research.

17 April 2025 in Microsystems & Nanoengineering
Verified
Journal Article
Open access
PDF file
XLXiang Li
Xiang Li
JCJie Chen
Jie Chen
YYYang Yang
Yang Yang
HCHongwei Cai
Hongwei Cai
ZAZheng Ao
Zheng Ao
Feng GuoFeng Guo
Feng Guo
Extracellular vesicles (EVs) show potential for early diagnosis of Alzheimer’s disease (AD) and monitoring of its progression. However, EV-based AD diagnosis faces challenges due to the small size and low abundance of biomarkers. Here, we report a fully integrated organic electrochemical transistor (OECT) sensor for ultrafast, accurate, and convenient point-of-care testing (POCT) of serum EVs from AD patients. By utilizing acoustoelectric enrichment, the EVs can be quickly propelled, significantly enriched, and specifically bound to the OECT detection area, achieving a gain of over 280 times response in 30 s. The integrated POCT sensor can detect serum EVs from AD patients with a limit of detection as low as 500 EV particles/mL and a reduced detection time of just two minutes. Furthermore, the integrated POCT sensors were used to monitor AD progression in an AD mouse model by testing the mouse Aβ EVs at different time courses (up to 18 months) and compared with the Aβ accumulation using high-resolution magnetic resonance imaging (MRI). This innovative technology has the potential for accurate and rapid diagnosis of Alzheimer’s and other neurodegenerative diseases, and monitoring of disease progression and treatment response.